Home Theravia

Theravia

acquired
-
Developer of treatments for rare and debilitating diseases
Basic
Enterprise Profile

Basic Information

Theravia is an international pharmaceutical company dedicated to providing treatments for patients with rare and debilitating diseases. The company develops therapies related to inherited metabolic disorders, hematology, oncology, immunology, and gene and cell therapy, thereby offering pharmaceutical products to meet patients' medical needs when they are unmet.
Theravia
France
15~50 people
January 01, 2002
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy Gene Therapy
Technology
Gene Technology Cell Technology
Concept
Immune System Diseases Metabolic Diseases # Nervous System Diseases Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy